US Patent 11173196 Vectors for expression of prostate-associated antigens
Patent 11173196 was granted and assigned to Pfizer on November, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
August 23, 2018
0
Date of Patent
November 16, 2021
0
Patent Applicant
Patent Application Number
16111120
0
Patent Inventor Names
Joseph John Binder
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11173196 Vectors for expression of prostate-associated antigens
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
